RBC Capital Cuts PT on Concordia Int'l (CXRX) to $27 Following Q2 REsults
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Boeing reports first revenue drop in 7 quarters as deliveries decline
- Oil settles lower as U.S. business activity cools, concerns over Middle East ease
- Yen on the brink, but Tesla pulls back
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Hasbro (HAS) brand strength sees earnings top expectations
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Crude Inventory Declined 6.4 Million Barrels Last Week
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
GMP Securities Downgrades Concordia Healthcare (CXRX) to Hold
August 15, 2016 8:23 AM EDTGMP Securities downgraded Concordia Healthcare (NASDAQ: CXRX) from Buy to Hold.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $10.13 yesterday.
... MoreCIBC Downgrades Concordia Healthcare (CXRX) to Sector Underperform
August 15, 2016 8:18 AM EDTCIBC downgraded Concordia Healthcare (NASDAQ: CXRX) from Sector Perform to Sector Underperform with a price target of $7.80.
For an analyst ratings summary and ratings history on Concordia Healthcare click here. For more ratings news on Concordia Healthcare click here.
Shares of Concordia Healthcare closed at $10.13 yesterday.
... MoreRBC Affirms Concordia (CXRX) at 'Outperform' as Q2 Profit Meets Lowered Expectations
August 12, 2016 9:24 AM EDTRBC Capital is out with initial commentary on Concordia International (Nasdaq: CXRX) following Q2 results and other matters announced earlier. The firm rates CXRX at Outperform wth a price target of $33.
Analyst Douglas Miehm commented, CXRX's Q2 results, which faced lower expectations from... More
Concordia Healthcare (CXRX) Misses Q2 EPS by 4c; CFO de Saldanha to Resign; Dividend Suspended
August 12, 2016 7:03 AM EDTConcordia Healthcare (NASDAQ: CXRX) reported Q2 EPS of $1.38, $0.04 worse than the analyst estimate of $1.42. Revenue for the quarter came in at $231.7 million versus the consensus estimate of $229.76 million.
Management Changes and Suspension of Dividend
The Company announced today that Adrian de Saldanha, Concordia's Chief Financial Officer, will be... More
